Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute

项目总结 罗斯威尔公园癌症研究所有为国家合作团体做出贡献的悠久传统 几十年来。这些贡献具有科学性、管理性和参与性(在 临床试验)。多年来，贡献是始终如一的，也是众多的。此应用程序总结了 其4个共同绩效指标(Levine/Ernstoff/Lele/Singh)和RPCI成员维持其承诺的意图 合作小组研究固有的许多优势：治疗进展；更好地理解 癌症生物学；癌症预防；提高癌症患者生活质量的手段；新技术的试点 药物和放射学、放射和外科技术；建立新的细胞和 预测、预测和治疗患者方法的分子进展；以及 推进患者维权工作。RPCI的调查人员及其支持人员充分认识到 及时、准确地提交数据和标本对实现这些目标十分重要。

PROJECT SUMMARY The Roswell Park Cancer Institute has had a long tradition of contributing to the national cooperative groups over many decades. Those contributions have been scientific, administrative, and participatory (enrollment on clinical trials). Contributions have been consistent and numerous over the years. This application summarizes the intent of its 4 Co-PIs (Levine/Ernstoff/Lele/Singh) and the membership of RPCI to sustain its commitment to the many strengths inherent to cooperative group research: therapeutic advances; a better understanding of the biology of cancer; cancer prevention; means to improve the quality of life of cancer patients; piloting of new drugs and radiologic and radiation and surgical techniques; establishing the relevance of new cellular and molecular advances to the predictive, prognostic, and therapeutic approaches to patients; and the advancement of patient advocacy. Investigators at RPCI and its supporting staff fully recognize the essential importance of the timely and accurate submission of data and specimens to achieve these aims.